And another...

I think you mean synthetic MERS.

Don't be so sure. Here, humanized MERS lung receptor in mice plus serial passage equals 100% lethality in mice at 5000 pfu inoculum.

ncbi.nlm.nih.gov/pmc/articles/P…

Perlman projects since SARS1 led to SARS2, MERS1 will lead to MERS2

Agree: zoonotic SARS1 was 10,000X less lethal than synthetic SARS2

What could synthetic, 30% lethal, MERS2 do?

Anticipating a MERS-like coronavirus as a potential pandemic threat thelancet.com/journals/lance…

The level of basic material science ignorance in the generation of engineers designing and building these disasters is beyond imagination.

And another...

This is important new information.

Dr. Matthew Goetz is leading the Evangeline trial. If you know someone with newly diagnosed #breastcancer have them consider Evangelinetrial.com for treatment.

Dr. Matthew Goetz and me at the AACR meeting in San Diego #breastcancer #CancerResearch

The 40mg EVANGELINE data is extremely encouraging as it shows that (Z)-endoxifen can not only stop ER+ breast cancer from growing, but it can also shrink or eliminate the tumor, as measured by MRI imaging. The depth of response at 40mg may even improve in the next phase of the…

Aug 16 2019 was tMRCA or time to Most Recent Common Ancestor of SARS-CoV-2 based on 83,688 viral samples.

Published Sep 2021

Getting excited about a recent paper on fall 2019 timing of the SARS2 origin is a sign you don't know the literature

ncbi.nlm.nih.gov/pmc/articles/P…

And another...

Robert Garry, one of the strongest proponents of the market origin, has retracted a paper he co-authored because the data was falsified.

Presenting the same data as if they were created under different experimental conditions.

I found the intermediate host here in Japan: the raccoon dog

Hallmark of a virus jumping hosts is initial rapid mutation rate during adaption, followed by return to natural RdRp error rate. This happened in the human to mink jump.

SAR2 had the same mutation clock from the beginning. First change was post-vaccines

academic.oup.com/ve/article/9/1…

mRNA vaccines seem to produce immune imprinting at high levels, thwarting the utility of new variant boosters. Not seen with inactivated virus vaccines.

Short version: new mRNA vaccines don't work.

cell.com/immunity/fullt…

This is Monali C. Rahalkar 's hypothesis first published here on X a little while ago.

I think it makes a lot of sense.

There are so many lab leaks that the Bayesian prior that a new outbreak is >98% likely to be spillover (where my Bayesian started; see article) needs re-examining

If it is starts in a college town/city c virus labs & not rural, the prior might be 50/50

zenodo.org/records/4642956